Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: United States NLM ID: 8700903 Publication Model: Print Cited Medium: Internet ISSN: 1998-3646 (Electronic) Linking ISSN: 02550857 NLM ISO Abbreviation: Indian J Med Microbiol Subsets: MEDLINE
    • Publication Information:
      Publication: 2021- : [New York] : Elsevier
      Original Publication: New Delhi : Indian Association of Medical Microbiologists
    • Subject Terms:
      Anti-Infective Agents/*pharmacology ; Salmonella typhi/*drug effects; Anti-Bacterial Agents/pharmacology ; Chloramphenicol/pharmacology ; Ciprofloxacin/pharmacology ; Drug Resistance, Bacterial ; Humans ; India ; Microbial Sensitivity Tests ; Nalidixic Acid/pharmacology ; Retrospective Studies ; Typhoid Fever/microbiology
    • Abstract:
      Purpose: Enteric fever is endemic in India with Salmonella Typhi being the major causative agent. Antibiotic therapy constitutes the mainstay of management. The present study was undertaken to find the susceptibility profile of Salmonella enterica var Typhi (S. Typhi) blood isolates in a tertiary care hospital between January 2001 and December 2012.
      Materials and Methods: A retrospective analysis of laboratory records was carried out. Conventional blood culture method was used until 2009; from January 2010 onwards BACTEC 9240 system has been in use. Salmonella were confirmed by serotyping using group and type specific antisera. Antibiotic susceptibility was performed using the disk diffusion method. In addition 116 isolates were subjected to minimum inhibitory concentration testing for chloramphenicol, ciprofloxacin, amoxicillin and nalidixic acid (NA) using agar dilution and for ceftriaxone and azithromycin using E-strips (Biomerieux).
      Result: A total of 1016 typhoidal salmonellae were obtained. The predominant serotype obtained was S. Typhi (852, 83.8%) followed by Salmonella enterica var Paratyphi A (164, 16.2%). We observed a re-emergence of susceptibility to first line antibiotics and a notable decline in multidrug resistant (MDR) strains. We also found all recent isolates resistant to NA and susceptible to third generation cephalosporins and 84.5% of isolates having decreasing ciprofloxacin susceptibility using revised criteria as per Clinical and Laboratory Standards Institute 2012 guidelines.
      Conclusion: There has been re-emergence of susceptibility to first line antibiotics and a notable decline in MDR strains of S. Typhi. We have a very high resistance to NA and decreasing susceptibility to ciprofloxacin. Third generation cephalosporins and azithromycin seem to be effective therapeutic options. Judicious use of these antibiotics is mandatory to prevent emergence of resistant strains.
    • Accession Number:
      0 (Anti-Bacterial Agents)
      0 (Anti-Infective Agents)
      3B91HWA56M (Nalidixic Acid)
      5E8K9I0O4U (Ciprofloxacin)
      66974FR9Q1 (Chloramphenicol)
    • Publication Date:
      Date Created: 20140410 Date Completed: 20141218 Latest Revision: 20220331
    • Publication Date:
      20221213
    • Accession Number:
      10.4103/0255-0857.129799
    • Accession Number:
      24713900